Eli Lilly said the U.S. government agreed to buy at least 100,000 doses of the company's newly authorized COVID-19 dual antibody cocktail for $210 million, with...
A panel of expert advisers to the U.S. Food and Drug Administration began a meeting to discuss Johnson & Johnson’s one-dose COVID-19 vaccine on Friday, setting...
The U.S. Food and Drug Administration on Feb. 25 approved storage and transportation of COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE at...
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to...
Tech Tumbles As Yields Surge, Meme Stocks Explode It's not just the surge in meme stocks that is a case of deja vu all over again:...
Many health experts believe that the Novavax COVID-19 vaccine candidate NVX-CoV237 offers potential advantages over competitors including Pfizer-BioNTech, Moderna, J&J, and AstraZeneca-Oxford.
Johnson & Johnson’s one-shot Covid-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration staff said in documents published on Wednesday, paving the...
FDA to allow Pfizer-BioNTech vaccine to be stored at higher temps: NYT (Reuters) – The U.S. Food & Drug Administration plans to approve Pfizer Inc and...
Covid-19 vaccine makers told Congress on Feb. 23 that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations.
Johnson & Johnson expects to be able to ship nearly 4 million doses of the company's Covid-19 vaccine upon authorization in the U.S.
Drugmakers should test any Covid-19 vaccines that have been retooled to combat new variants of the coronavirus in clinical trials designed to track the immune response...
Drug developer Novavax Inc. completed enrolling 30,000 volunteers in a late-stage study of the company's Covid-19 vaccine in the United States and Mexico.
Johnson & Johnson submitted data to the World Health Organization (WHO) for emergency use listing of the company's Covid-19 vaccine, which would allow for wider access...
B. Riley analyst Mayank Mamtani has long banged the drum for Novavax (NVAX). The latest developments surrounding the company have only reaffirmed his bullish outlook for...
Novavax announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to provide 1.1 billion doses of the company's Covid-19 vaccine candidate NVX-CoV2373 for the COVAX...
Pfizer Inc. and BioNTech SE started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women.
With a third of adults saying they likely won't get the vaccine and 20% of the population under 16, the US has a herd immunity math...
The US has a herd immunity math problem, with a COVID-19 vaccine not yet approved for children under 16 and a third of adults saying they...
Kroger Co.'s healthcare division has partnered with Gauss to provide a smartphone-enabled, at-home COVID-19 rapid antigen test kit to patients. The antigen test is currently awaiting...
On Feb. 12, medical technology company Becton Dickinson & Co announced that it had received emergency use authorization (EUA) from the U.S. Food and Drug Administration...
A molecular test from Becton Dickinson that detects viruses that cause Covid-19 as well as influenza and produces result in 2-3 hours was given emergency use...
Bio-Rad Laboratories outperformed fourth-quarter earnings and sales estimates as the the life science research and clinical diagnostic comany benefited from strong demand for its COVID-19 products...
What does it take to move a stock price from $0.29 to $15.81 -- an increase of 5,350% -- in just 18 days? Coronavirus, of course....
The U.S. Food and Drug Administration granted Emergency Use Authorization (EUA) to a combination of Eli Lilly and AbCellera’s monoclonal antibody bamlanivimab and the Lilly antibody etesevimab...
The FDA has granted an emergency license for Eli Lilly’s COVID-19 antibody combination therapy, to reduce chances of severe COVID-19
CNBC Transcript: Johnson & Johnson Chairman & CEO Alex Gorsky speaks with Meg Tirrell live during CNBC’s Healthy Returns Spotlight today on the company’s one-shot coronavirus...
The United States is spiraling. Seven-day averages for positive COVID-19 cases have exceeded 250,000 per day, having risen sharply after the Thanksgiving holiday and rising again...
Novavax (NVAX) was the coronavirus stock to hold last year, as the company punched far above its weight and delivered investors incredible returns.
Johnson & Johnson has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) of its investigational single-dose COVID-19 vaccine...
Hospitalizations Fall In NY, But Not As Quickly As Other COVID Hotspots: Live Updates Summary: Hospitalizations fall in NY, but not as fast as other hotspots...